Surgery Partners
SGRY
151 hedge funds and large institutions have $4.48B invested in Surgery Partners in 2023 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 63 increasing their positions, 40 reducing their positions, and 29 closing their positions.
58% more repeat investments, than reductions
Existing positions increased: 63 | Existing positions reduced: 40
26% more capital invested
Capital invested by funds: $3.56B → $4.48B (+$927M)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
6% less funds holding
Funds holding: 161 → 151 (-10)
28% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 29
40.34% less ownership
Funds ownership: 143.26% → 102.91% (-40%)
92% less call options, than puts
Call options by funds: $495K | Put options by funds: $6.15M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$38.9M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$25M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
+$16.7M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$14.9M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ITP
Iron Triangle Partners
Cos Cob,
Connecticut
|
-$15.1M |
| 2 |
LP
LMR Partners
London,
United Kingdom
|
-$13.9M |
| 3 |
DCP
Durable Capital Partners
Bethesda,
Maryland
|
-$13.1M |
| 4 |
Goldman Sachs
New York
|
-$12.6M |
| 5 |
CC
Cannell & Co
New York
|
-$11.8M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
JF
176
Jump Financial
Chicago,
Illinois
| – | -$203K | -7,304 | Closed |
|
|
IA
177
IFP Advisors
Tampa,
Florida
| – | -$34K | -2,100 | Closed |
|
178
Rockefeller Capital Management
New York
| – | -$47K | -1,709 | Closed |
|
|
NA
179
NewEdge Advisors
New Orleans,
Louisiana
| – | -$1.14K | -41 | Closed |
|
|
CS
180
Comerica Securities
Detroit,
Michigan
| – | -$167 | -6 | Closed |
|
SGRY Hedge Fund Activity: Q1 2023 in Review
151 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Surgery Partners (SGRY) for Q1 2023, worth a combined $4.48B — up 26% from $3.56B a quarter earlier.
Sellers outnumbered buyers: 29 funds closed out of SGRY and 21 opened new positions — a net loss of 8 holders — while 40 trimmed existing stakes and 63 added.
The largest buyer was Invesco, adding an estimated $38.9M. The largest seller was Iron Triangle Partners, cutting an estimated $15.1M.
- 151 institutional investors held Surgery Partners (SGRY) as of Q1 2023, down from 161 in Q4 2022.
- Funds reported $4.48B of Surgery Partners stock for Q1 2023, up 26% quarter-over-quarter.
- 21 funds opened new Surgery Partners positions in Q1 2023 and 29 closed out, a net change of -8 holders.
- The largest Surgery Partners buyer in Q1 2023 was Invesco, an estimated $38.9M added.
- The largest Surgery Partners seller in Q1 2023 was Iron Triangle Partners, an estimated $15.1M sold.
Based on aggregated 13F filings for Q1 2023.